1. Home
  2. TMDX

TMDX

TransMedics Group Inc.

Logo TransMedics Group Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-18-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Founded: 1998 Country:
United States
United States
Employees: N/A City: ANDOVER
Market Cap: 2.8B IPO Year: 2019
Target Price: $95.14 AVG Volume (30 days): 723.0K
Analyst Decision: Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.77 EPS Growth: N/A
52 Week Low/High: $36.42 - $99.63 Next Earning Date: 04-30-2024
Revenue: $241,623,000 Revenue Growth: 158.53%
Revenue Growth (this year): 54.92% Revenue Growth (next year): 33.51%

Share on Social Networks: